Caroline Levy's most recent trade in Celsius Holdings Inc was a trade of 70,000 Common Stock Option done . Disclosure was reported to the exchange on March 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celsius Holdings Inc | Caroline Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 70,000 | 0 | - | - | Common Stock Option | |
| Celsius Holdings Inc | Caroline Levy | Director | Sale of securities on an exchange or to another person at price $ 26.84 per share. | 11 Mar 2025 | 70,000 | 42,756 (0%) | 0% | 26.8 | 1,878,800 | Common Stock, $0.001 par value per share |
| Celsius Holdings Inc | Caroline Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.84 per share. | 11 Mar 2025 | 70,000 | 112,756 (0%) | 0% | 4.8 | 338,800 | Common Stock, $0.001 par value per share |
| Celsius Holdings Inc | Caroline Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 4,865 | 42,756 (0%) | 0% | 0 | Common Stock, $0.001 par value per share | |
| Celsius Holdings Inc | Caroline Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.84 per share. | 13 Mar 2024 | 20,000 | 57,891 (0%) | 0% | 4.8 | 96,800 | Common Stock, $0.001 par value per share |
| Celsius Holdings Inc | Caroline Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 20,000 | 70,000 | - | - | Common Stock Option | |
| Celsius Holdings Inc | Caroline Levy | Director | Sale of securities on an exchange or to another person at price $ 94.77 per share. | 13 Mar 2024 | 20,000 | 37,891 (0%) | 0% | 94.8 | 1,895,400 | Common Stock, $0.001 par value per share |
| Celsius Holdings Inc | Caroline Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,576 | 37,891 (0%) | 0% | 0 | Common Stock, $0.001 par value per share | |
| Celsius Holdings Inc | Levy Caroline | Director | 31 Dec 2023 | 75,000 | 36,315 (0%) | 0% | 4.8 | 362,250 | Common Stock, $0.001 par value per share | |
| Celsius Holdings Inc | Caroline Levy | Director | 31 Dec 2023 | 75,000 | 90,000 | - | - | Common Stock Option | ||
| Celsius Holdings Inc | Caroline Levy | Director | Sale of securities on an exchange or to another person at price $ 171.67 per share. | 11 Aug 2023 | 25,000 | 5,500 (0%) | 0% | 171.7 | 4,291,750 | Common Stock |
| Celsius Holdings Inc | Caroline Levy | Director | Sale of securities on an exchange or to another person at price $ 172.35 per share. | 11 Aug 2023 | 5,500 | 30,500 (0%) | 0% | 172.4 | 947,925 | Common Stock |
| Celsius Holdings Inc | Caroline Levy | Director | Sale of securities on an exchange or to another person at price $ 134.51 per share. | 18 May 2023 | 2,200 | 17,605 (0%) | 0% | 134.5 | 295,922 | Common Stock |
| Celsius Holdings Inc | Caroline Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 1,105 | 3,855 (0%) | 0% | - | Common Stock | |
| Niagen Bioscience Inc. | Caroline Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Celsius Holdings Inc | Caroline Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 16,500 | 17,605 (0%) | 0% | - | Common Stock | |
| Celsius Holdings Inc | Caroline Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 2,200 | 19,805 (0%) | 0% | - | Common Stock |